SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome

Guillain-Barre Syndrome (GBS) has been repeatedly reported as a neurological complication of COVID-19 (post-COVID GBS [PCG]). Whether the introduction of SARS-CoV-2 vaccines reduced the prevalence of PCG is unknown. This narrative review aimed to compare the number of published PCG cases between the...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Matovu, Daniel, Scorza, Fulvio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189101/
https://www.ncbi.nlm.nih.gov/pubmed/35751951
http://dx.doi.org/10.1016/j.clinsp.2022.100064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189101/
https://www.ncbi.nlm.nih.gov/pubmed/35751951
http://dx.doi.org/10.1016/j.clinsp.2022.100064

Ejemplares similares